Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Dexter L. Morris"'
Autor:
Christian Wolf, Jagdev Sidhu, Christian Otoul, Dexter L Morris, Jennifer Cnops, Jorg Taubel, Barbara Bennett
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58438 (2013)
Lymphocyte inhibition by antagonism of α4 integrins is a validated therapeutic approach for relapsing multiple sclerosis (RMS).Investigate the effect of CDP323, an oral α4-integrin inhibitor, on lymphocyte biomarkers in RMS.Seventy-one RMS subjects
Externí odkaz:
https://doaj.org/article/51d60e745c2a4d8fa251d479697ccc5e
Autor:
Dexter L. Morris, Wayne D. Rosamond, Kelly R. Evenson, Julie C. Lellis, Jane H. Brice, Semra Aytur, Jennifer Briley Christian
Publikováno v:
Prehospital Emergency Care. 12:366-371
Prehospital care of stroke and chest pain patients is dependent on adequate emergency medical services (EMS) education and evidence-based protocols. We sought to describe the amount of education offered, community outreach implemented, and protocols
Autor:
David Kingdon, Dexter L. Morris, Julie C. Lellis, Wayne D. Rosamond, Jane H. Brice, Kelly R. Evenson
Publikováno v:
Prehospital Emergency Care. 11:298-306
We describe the development and implementation of the North Carolina Rapid Response to Stroke (NCRRS) project--a community-based online education project developed for 911 telecommunicators and EMS personnel.Two online courses, one for 911 telecommun
Autor:
Arthur M. Pancioli, Laura P. Kimble, Debra K. Moser, Dexter L. Morris, Kelly R. Evenson, Rashmi Kothari, Alan S. Go, Angelo A. Alonzo, Julie Johnson Zerwic, Barbara Riegel, Mark J. Alberts, George A. Mensah, Kathleen Dracup, Janet B. Croft, Mary M. Hand
Publikováno v:
Circulation. 114:168-182
Patient delay in seeking treatment for acute coronary syndrome and stroke symptoms is the major factor limiting delivery of definitive treatment in these conditions. Despite decades of research and public education campaigns aimed at decreasing patie
Publikováno v:
Emergency Medicine Clinics of North America. 20:717-729
The landscape of acute stroke care has changed dramatically in the last decade. Even before the approval of tissue plasminogen activator for acute stroke in 1996, organized acute stroke care was initiated at several hospitals and the pharmaceutical i
Publikováno v:
Neuroepidemiology. 20:65-76
Current guidelines emphasize the need for early stroke care. However, significant delays occur during both the prehospital and in-hospital phases of care, making many patients ineligible for stroke therapies. The purpose of this study was to systemat
Publikováno v:
Stroke. 31:2585-2590
Background and Purpose —Patient delays in seeking treatment for stroke and delays within the Emergency Department (ED) are major factors in the lack of use of thrombolytic therapy for stroke. The Genentech Stroke Presentation Survey was a multicent
Publikováno v:
Academic Emergency Medicine. 6:218-223
Objective: To delineate components of delay within the hospital ED for patients presenting with symptoms of stroke. Methods: A prospective registry of patients presenting to the ED with signs or symptoms of stroke was established at a university hosp
Autor:
Christian Wolf, Jagdev S. Sidhu, Jennifer Cnops, Jorg Taubel, Christian Otoul, Dexter L. Morris, Barbara Bennett
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 3, p e58438 (2013)
PLoS ONE, Vol 8, Iss 3, p e58438 (2013)
BACKGROUND: Lymphocyte inhibition by antagonism of α4 integrins is a validated therapeutic approach for relapsing multiple sclerosis (RMS). OBJECTIVE: Investigate the effect of CDP323, an oral α4-integrin inhibitor, on lymphocyte biomarkers in RMS.
Publikováno v:
International journal of stroke : official journal of the International Stroke Society. 4(3)
The purpose of this study was to systematically review and summarize prehospital and in-hospital stroke evaluation and treatment delay times. We identified 123 unique peer-reviewed studies published from 1981 to 2007 of prehospital and in-hospital de